NIH’s Moonshot Project To Globally Register Medicinal Ingredients
January 31, 2020 | What’s in a name? When it comes to ingredients found in medicine, quite a lot of important detail. That’s why NIH’s NCATS (National Center for Advancing Translational Sciences) has been working to marshal a definitive resource for medicinal ingredients.
We would like to keep you updated with Rancho News that will include papers, posters, meetings we will be attending, fun events, new Ranchers and much more.
RANCHO BIOSCIENCES EXPANDS TO NEW OFFICES IN SAN DIEGO
Rancho BioSciences is continuing to grow globally. At our headquarters in San Diego we ran out of room so we moved to a larger space with lots of windows, multiple conference rooms, a hang out area and kitchen. Our new address is:
Rancho BioSciences, LLC
16955 Via Del Campo, Suite 200
Andy Hope joins Rancho BioSciences Business Development Team
Andy is focused on Business Development at Rancho Biosciences. He brings over 30 years’ experience in consultative selling of complex solutions and services to pharma and biotech companies. After gaining his PhD in Computational Chemistry from University College London he spent the first 10 years working at two of the pioneering companies in molecular modeling, Chemical Design and Biosym Technologies. He then spent 7 years at Aspen Technology before joining IBM Healthcare and Lifesciences for 6 years. Early in 2009 he joined GeneGo prior to their acquisition by Thomson Reuters in 2011 to became part of their Intellectual Property & Science Division. He spent a further 5 years at TR where he led the Discovery and Translational Sciences business development team for N. America and Europe. After a brief stint at Bioreference Labs/GeneDx he spent over a year at Cyclica prior to joining RBS.
Konstantin Bobkov joins Rancho BioSciences as a Bioinformatics Scientist
Konstantin has over 7 years of experience in the field of computational biology. As a member of the bacTRAP group at Takeda California, Konstantin identified and proposed novel drug targets and analyzed molecular profiles of known drugs and tool compounds to identify their mechanisms of action. He also designed and developed bioinformatics software to retrieve, analyze and visualize in-house RNA-seq and microarray data. As a member of the Research Informatics team at Synthetic Genomics, Konstantin developed and implemented an algorithm for automatic transgene optimization in green algae, developed bioinformatics pipelines and performed bioinformatics support for multiple research teams within the company.
Konstantin earned his Bachelor’s degree in Physics from Taras Shevchenko National University of Kiev, Ukraine. He completed his PhD in Theoretical High Energy Physics at the University of North Carolina, Chapel Hill under the mentorship of Professor Louise Dolan. Postdoctoral training was completed at Duke University with Professor Ronald Jaczszak, The Ohio State University with Professor Stuart Raby, and UC San Francisco with Professor Jun Song in the areas of medical imaging, theoretical physics and computational biology.